Prostate Cancer

Top Story

Landmark prostate cancer screening trial may have misrepresented data

May 5, 2016

The rates of PSA screening reported in the control group of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial may have been inaccurately reported, according to a letter to the editor published in The New England Journal of Medicine.

As such, recent recommendations regarding the use of PSA — including recommendations against screening issued by the U.S. Preventive Services Task Force (USPSTF) in 2012 — may need to be reassessed, according to Jim C. Hu, MD, MPH, Ronald Lynch professor of urologic oncology at Weill Cornell Medicine and director of the LeFrak Center for Robotic Surgery at NewYork-Presbyterian Hospital.

In the Journals

Low vitamin D increases risk for adverse pathology of localized prostate cancer

May 5, 2016
Vitamin D deficiency or insufficiency appeared associated with elevated risk for adverse pathology in men with localized prostate cancer who underwent radical…
In the Journals

Zoledronic acid reduces skeletal complications for men with progressive bony prostate cancer

May 3, 2016
The addition of zoledronic acid to docetaxel significantly reduced the rate of skeletal-related events but did not prolong OS or clinical PFS among men with metastatic…

Indiana University Health Simon Cancer Center yoga program eases stress associated with diagnosis, treatment

May 2, 2016
Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.A patient’s quality of life may…
CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Video

Routine PSA screening for most men not ready for ‘prime time’

February 10, 2015
More »
Featured
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Landmark prostate cancer screening trial may have misrepresented data

May 5, 2016
The rates of PSA screening reported in the control group of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial may have been…

In the Journals

Low vitamin D increases risk for adverse pathology of localized prostate cancer

May 5, 2016
Vitamin D deficiency or insufficiency appeared associated with elevated risk for adverse pathology in men with localized prostate cancer who…

In the Journals

Zoledronic acid reduces skeletal complications for men with progressive bony prostate cancer

May 3, 2016
The addition of zoledronic acid to docetaxel significantly reduced the rate of skeletal-related events but did not prolong OS or clinical PFS among…

Indiana University Health Simon Cancer Center yoga program eases stress associated with diagnosis, treatment

May 2, 2016
Yoga therapy is an integrative medicine technique that supplements the traditional treatment regimens patients with cancer undergo.A patient’s…

Meeting News CoverageVideo

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
NEW ORLEANS — Kunle Odunsi, MD, PhD, FRCOG, FACOG, deputy director of Roswell Park Cancer Institute and executive director of the…

In the JournalsPerspective

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…

In the JournalsPerspective

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…

Meeting News CoverageVideo

VIDEO: Innovation in CAR T-cell design may help improve safety, efficacy

April 25, 2016
NEW ORLEANS — Marco L. Davila, MD, PhD, medical oncologist at Moffitt Cancer Center, reacts to an abstract presented at the American…

Meeting News Coverage

Walking, other physical activity may decrease risk for prostate cancer death

April 23, 2016
NEW ORLEANS — Greater physical activity before and after cancer diagnosis significantly decreased risk for prostate cancer-specific mortality…

Meeting News CoverageVideo

VIDEO: Neighborhood variables associated with prostate cancer aggressiveness

April 20, 2016
NEW ORLEANS — Neighborhood poverty level and mode of transportation to work appeared associated with disease aggressiveness among patients with…

More Headlines »
morganatic-roan